Paperpal Prime Logo

Current Gene Therapy : Impact Factor & More

eISSN: 1875-5631pISSN: 1566-5232

Aims and Scope of Current Gene Therapy

Current Gene Therapy is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Liang Cheng (Harbin Medical University Harbin, China). The focus of this journal is pre-clinical or clinical research on gene therapy. Formats of publication include original research reports, review papers, and rapid communications ("letters"). Less

Key Metrics

CiteScore
5.8
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q3Genetics
SNIP
0.89
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Current Gene Therapy

Current Gene Therapy Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher BENTHAM SCIENCE PUBL LTD
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2000
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Current Gene Therapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Current Gene Therapy

Single-cell Transcriptomics Inference of Neutrophil-mast Cell Communication Programs in Periodontitis.
  • 17 Jun 2026
  • Current gene therapy
GULP1 in Ovarian Cancer: Expression, Biological Function, and Clinical Significance.
  • 15 Jun 2026
  • Current gene therapy
Surface Functionalization of 3D-Printed Porous Ti-6Al-4V Scaffolds with PDA‑mHA-Col I Composite Coating Drives Macrophage Polarization toward the M2 Phenotype and Promotes Immunomodulation: An In Vitro Study.
  • 1 Jun 2026
  • Current gene therapy
Single‑cell Transcriptomic Profiling of Bone Marrow Mesenchymal Stem Cells Reveals Lineage Heterogeneity and Dysregulated Osteoblast Genes in Osteoporosis Versus Osteoarthritis.
  • 1 Jun 2026
  • Current gene therapy
A Telomere-Maintenance Three-Gene Model for the Prognostic Prediction in Intrahepatic Cholangiocarcinoma and Multi-Cohort Validation.
  • 30 May 2026
  • Current gene therapy
APOL3 Orchestrates Metastasis and Enzalutamide Resistance via STAT3-DAB2IP Signaling in Prostate Cancer.
  • 25 May 2026
  • Current gene therapy
Single-cell Transcriptomics Inference of Neutrophil-mast Cell Communication Programs in Periodontitis.
  • 17 Jun 2026
  • Current gene therapy
GULP1 in Ovarian Cancer: Expression, Biological Function, and Clinical Significance.
  • 15 Jun 2026
  • Current gene therapy
Surface Functionalization of 3D-Printed Porous Ti-6Al-4V Scaffolds with PDA‑mHA-Col I Composite Coating Drives Macrophage Polarization toward the M2 Phenotype and Promotes Immunomodulation: An In Vitro Study.
  • 1 Jun 2026
  • Current gene therapy
Single‑cell Transcriptomic Profiling of Bone Marrow Mesenchymal Stem Cells Reveals Lineage Heterogeneity and Dysregulated Osteoblast Genes in Osteoporosis Versus Osteoarthritis.
  • 1 Jun 2026
  • Current gene therapy
A Telomere-Maintenance Three-Gene Model for the Prognostic Prediction in Intrahepatic Cholangiocarcinoma and Multi-Cohort Validation.
  • 30 May 2026
  • Current gene therapy
APOL3 Orchestrates Metastasis and Enzalutamide Resistance via STAT3-DAB2IP Signaling in Prostate Cancer.
  • 25 May 2026
  • Current gene therapy

FAQs on Current Gene Therapy